Acepodia, Inc.

As of June 30, 2026, Acepodia, Inc. carries a market capitalization of 7.75B, placing it among publicly traded companies globally. Its enterprise value stands at 4.55B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Acepodia, Inc. has 582.87M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Acepodia, Inc. maintains a current ratio of 21.03, meaning it holds 21.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 4.63, indicating elevated leverage, while an interest coverage ratio of -165.49 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Acepodia, Inc. posted a negative return on equity (ROE) of -7.89, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -7.35, reflecting losses generated across the asset base.

As of the close on October 22, 2026, Acepodia, Inc.'s stock has declined approximately 20.06% over the past 52 weeks. The 50-day moving average sits at 12.62, while the 200-day moving average is 13.02.

These figures cover the twelve months ended June 30, 2026. EBITDA reached -428.94M, while operating income came in at -491.11M.

As of June 30, 2026, Acepodia, Inc. holds 3.44B in cash and equivalents against 234.58M in total debt, resulting in a net debt position of -3.44B. Total book value stands at 5.07B, with working capital of 3.42B providing operational flexibility.

Acepodia, Inc. produced -369.01M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -8.03M in capital expenditures, free cash flow totaled -377.03M - equivalent to -0.65 per share.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -4.88: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 0.30, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Acepodia, Inc. shareholders.